Behind the scenes at how Merck sought to “neutralize” doctors who went against Vioxx, or supported Celebrex
It shows how physicians are merely pawns in a billion dollar game played by the pharmaceutical industry.
Similar Posts:
- Banning industry sponsorship of CME has wide ranging repercussions
- Direct to consumer drug advertising is money wasted
- How Google Sidewiki will impact drug company websites




{ 2 comments }
Now this is the kind of legislation I like. Not only does it institute caps for businesses that range beyond medical institutions/practices, it also has rules to reform the court proceeding processes (although the article doesn’t flesh those out, unfortunately). Caps are very nice, but I always felt they’re only part of the solution.
And, for the patients’ rights advocates, any doctor with three or more malpractice claims against them gets investigated. That ought to silence a lot of the med-mal horror stories about cases where a practitioner gets a slew of complaints against them.
Unfortunately, this bil passed by a very thin margin. Med-mal legislation has failed before with more support in other states, so I’m simultaneously hopeful and cynical about its prospects.
Sorry … this was meant for the story below.
Am I the only one who has ben having trouble with blogger’s new commenting system lately? It seems like it ignores endtags, posts to the wrong entry and makes it impossible to delete.
If this keeps up, I’m moving to Moveable Type.
Comments on this entry are closed.